Nightstar
Gene therapy startup
Nightstar has raised €39M across 1 funding round from 4 investors, most recently a Series C round in Jul 2017. Based in UK; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€39M
€38,633,242
Funding rounds
1
Investors
4
distinct backers
Active since
2017-07
latest 2017-07
Funding by year
EUR raised per yearNightstar — funding by year — interactive chart.
Data table
| Nightstar — funding by year | |
|---|---|
| 2017 | €39M |
Signals
High confidenceRaise-next likelihood10
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-07-25 | Series C | €39M | New Enterprise Associates,Redmile Group,Syncona Partners,Wellington Partners | View deal → |
Related news
Similar companies
same sector, similar size- ALung Technologies€34MUK · Healthtech
- ReViral€37MUK · Healthtech
- Vascutek€37MUK · Healthtech
- StarLeaf€37MUK · Healthtech
- Cambridge Medical Robotics€43MUK · Healthtech
- Push Doctor€46MUK · Healthtech
Global coverage: FundingData